share_log

Truist Securities Maintains Buy on Regeneron Pharmaceuticals, Maintains $1135 Price Target

Truist Securities Maintains Buy on Regeneron Pharmaceuticals, Maintains $1135 Price Target

Truist Securities维持对再生元制药的买入,维持1135美元的目标股价
Moomoo 24/7 ·  03/26 09:35

Truist Securities analyst Robyn Karnauskas maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Buy and maintains $1135 price target.

Truist Securities分析师罗宾·卡瑙斯卡斯维持Regeneron Pharmicals(纳斯达克股票代码:REGN)的买入并维持1135美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发